醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

Archive > Volume 10 Issue 2 > 2018,10(2):214-221. DOI:10.1016/j.chmed.2018.03.007 Prev Next

Hederacolchiside A1通過(guò)調(diào)節(jié)PI3K / Akt / mTOR信號(hào)通路誘導(dǎo)腫瘤細(xì)胞凋亡

Original articles

Hederacolchiside A1 suppresses proliferation of tumor cells by inducing apoptosis through modulating PI3K/Akt/mTOR signaling pathway

  • Article
  • Figures
  • Metrics
  • Preview PDF
  • Reference
  • Related
  • Cited by
  • Materials
    摘要:
    目的：Hederacolchiside A1在體外對(duì)各種腫瘤細(xì)胞表現(xiàn)出細(xì)胞抑制和細(xì)胞毒活性，但其機(jī)制尚不清楚。本研究主要探討白頭翁中提取分離的Hederacolchiside A1的抗腫瘤活性和機(jī)制。 方法：用MTT法檢測(cè)Hederacolchiside A1對(duì)A549，SMMC-7721，BEL-7402和MCF-7細(xì)胞增殖的抑制作用。通過(guò)流式細(xì)胞術(shù)分析鑒定經(jīng)Hederacolchiside A1處理的腫瘤細(xì)胞凋亡狀況。 結(jié)果：根據(jù)Western blotting和JC-1染色結(jié)果：hederacolchiside A1降低腫瘤細(xì)胞線粒體膜電位和Bcl-2蛋白表達(dá)水平，并升高cleaved caspase-3蛋白表達(dá)水平。此外，hederacolchiside A1可有效地抑制磷脂酰肌醇（-3）激酶（PI3K），蛋白激酶B（Akt）和雷帕霉素靶蛋白（mTOR）表達(dá)水平。體內(nèi)研究表明，在肝癌H22移植瘤模型中，Hederacolchiside A1（3.0，4.5和6.0mg / kg，ip）可顯著抑制腫瘤的重量；在人乳腺癌MCF-7移植瘤模型中，用Hederacolchiside A1（3.25,7.5和15.0mg / kg，ig）進(jìn)行治療，觀察到類似的抑制活性。 結(jié)論：這些數(shù)據(jù)表明，Hederacolchiside A1可通過(guò)調(diào)節(jié)PI3K / Akt / mTOR信號(hào)傳導(dǎo)途徑誘導(dǎo)腫瘤細(xì)胞凋亡從而抑制腫瘤細(xì)胞的增殖。

    Abstract:
    Hederacolchiside A1, exhibits cytostatic and cytotoxic activity against various cancer cells in vitro, however, the mechanism is not well understood. In this study, Hederacolchiside A1 from Pulsatilla chinensis was isolated and tested its anticancer activity and mechanism. Hederacolchiside A1 could inhibit proliferation of A549, SMMC-7721, BEL-7402, and MCF-7 cells by MTT assay. Investigations of apoptosis of treated cancer cells were identified in hederacolchiside A1 by flow cytometric analysis of annexin V expression. Based on the results of western blotting and JC-1 staining, hederacolchiside A1 reduced the mitochondrial membrane potential and Bcl-2 protein levels, whereas cleaved caspase-3 was higher. Furthermore, hederacolchiside A1 effectively inhibited the phosphorylations of phosphatidylinositol 3 kinase (PI3K), protein kinase B (Akt), and mammalian target of rapamycin (mTOR). In vivo study showed that hederacolchiside A1 (3.0, 4.5, and 6.0 mg/kg, ip) could significantly inhibit the weight of tumor in an H22 xenograft model. Similar inhibitory activities were observed when the compound (3.25, 7.5, and 15.0 mg/kg, ig) was tested in nude mice xenograft tumor models using human breast carcinoma MCF-7 cells. These data indicated that hederacolchiside A1 suppressed the proliferation of human tumor cells by inducing apoptosis through modulating the PI3K/Akt/mTOR signaling pathway.

    關(guān)鍵詞:
    細(xì)胞凋亡; Hederacolchiside A1; 線粒體途徑;PI3K-Akt-mTOR途徑

    Keywords:


    Project Supported:
    This paper was funded by the National Sciences Foundation of China (No.81273402, 81573548).

    Clc Number:

WeChat

Mobile website